IMPORTANT NOTICE
The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization with the mission of serving life science professionals through promoting interaction and collaboration locally and globally. Because of the serious concerns among our members about the escalating tension between US-China technology and trade exchange, and recent development in political rhetorics and policies that single out professionals of Chinese descent as threats to U.S. national interest, CABS would like to issue the following statements in solidarity with other communities.
Please see the links:
1. Racial profiling harms science
2. Committee of 100 Condemns Chinese American Racial Profiling
1) CABS respects U.S intellectual property law. CABS has provided and will continue to provide trainings to educate its members on intellectual property law.
2) CABS strongly condemns racial profiling targeting Chinese Americans or Americans of any ethnic group based on their ethnic heritage or national origin. Racial discrimination or profiling is inconsistent with American values and will in the long run only weaken American national interest.
If you have any questions or comments, please email info@cabsweb.org.
Sincerely,
CABS Board
CABS is a non-profit organization for life sciences trusted by our professional members. Join the community!
March 26, 2022 @ 3:30 pm
October 14, 2021 @ 10:00 am
September 18, 2021 @ 9:00 am
July 17, 2021 @ 10:00 am
July 15, 2021 @ 11:30 am
June 26, 2021 @ 2:00 pm
May 26, 2021 @ 8:30 am
May 8, 2021 @ 8:00 am
April 16, 2021 @ 8:30 am
March 23, 2021 @ 8:30 am
March 19, 2021 @ 10:30 am
March 9, 2021 @ 8:30 am
February 16, 2021 @ 12:00 pm
January 19, 2021 @ 11:00 am
December 21, 2020 @ 11:00 am
December 15, 2020 @ 8:45 am
December 8, 2020 @ 8:45 am
December 7, 2020 @ 5:00 pm
November 14, 2020 @ 1:00 pm
November 13, 2020 @ 11:00 am
October 29, 2020 @ 4:00 pm
October 17, 2020 @ 3:00 pm
September 17, 2020 @ 8:30 am
August 22, 2020 @ 2:00 pm
August 18, 2020 @ 9:00 am
July 28, 2020 @ 6:00 am
June 27, 2020 @ 4:00 pm
June 27, 2020 @ 4:00 pm
June 20, 2020 @ 2:00 pm
May 2, 2020 @ 5:00 pm
April 10, 2020 @ 11:30 am
March 24, 2020 @ 5:00 pm
March 16, 2020 @ 8:30 am
March 9, 2020 @ 8:45 am
February 27, 2020 @ 12:00 pm
January 21, 2020 @ 8:45 am
January 13, 2020 @ 8:00 am
October 12, 2019 @ 8:30 am
June 11, 2019 @ 8:45 am
May 18, 2019 @ 2:00 pm
May 6, 2019 @ 8:45 am
April 25, 2019 @ 8:30 am
March 17, 2019 @ 12:30 pm
March 11, 2019 @ 8:30 am
March 7, 2019 @ 8:45 am
February 12, 2019 @ 6:00 pm
February 7, 2019 @ 8:30 am
January 23, 2019 @ 6:00 pm
January 18, 2019 @ 11:00 am
December 14, 2018 @ 11:00 am
December 12, 2018 @ 6:00 pm
December 11, 2018 @ 9:30 am
December 4, 2018 @ 8:45 am
November 16, 2018 @ 8:45 am
November 15, 2018 @ 6:30 pm
November 10, 2018 @ 1:00 pm
September 20, 2018 @ 12:00 am
April 7, 2018 @ 1:30 pm
March 30, 2018 @ 9:00 am
January 31, 2018 @ 12:00 pm
December 15, 2017 @ 5:00 pm
October 28, 2017 @ 3:00 pm
October 22, 2017 @ 3:00 pm
October 1, 2017 @ 8:00 pm
September 16, 2017 @ 1:30 pm
August 19, 2017 @ 6:30 pm
August 5, 2017 @ 8:00 am
July 28, 2017 @ 11:00 am
July 22, 2017 @ 1:30 pm
June 28, 2017 @ 8:30 am
May 8, 2017 @ 12:00 am
May 5, 2017 @ 12:00 am
April 15, 2017 @ 4:00 pm
January 13, 2017 @ 6:00 pm
December 8, 2016 @ 6:00 pm
October 15, 2016 @ 1:30 pm
October 8, 2016 @ 8:30 am
September 12, 2016 @ 6:30 pm
September 10, 2016 @ 1:00 pm
August 20, 2016 @ 1:00 pm
August 11, 2016 @ 10:00 am
May 13, 2016 @ 12:00 pm
April 7, 2016 @ 6:00 pm
April 5, 2016 @ 8:00 am
March 26, 2016 @ 8:00 am
March 19, 2016 @ 1:30 pm
February 18, 2016 @ 6:00 pm
February 16, 2016 @ 6:00 pm
February 5, 2016 @ 10:00 am
January 20, 2016 @ 9:30 am
OUR MISSION
To SERVE biopharmaceutical professionals with professional interests in China and promote professional interactions locally and across the Pacific
To FOSTER business opportunities and exchanges in the life science industry between the U.S. and China
To PROMOTE public awareness of progress and development in the pharmaceutical and biotechnological industry
To COLLABORATE with other organizations in areas of mutual interest
The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professionals in the biopharmaceutical industry. CABS is headquartered in San Francisco Bay Area, California. This is the home of the Silicon Valley, the birthplace of biotechnology and one of the largest biomedical cluster with the highest venture capital investment in the world. There are more than a thousand biopharmaceutical/biotech companies in this area, including several large biopharmaceuticals such as Amgen, Genentech and Gilead. CABS is a highly influential association with more than 3000 members and subscribers in the life sciences industry. About 70% of our members have PhD degree relating to life sciences. A considerable proportion of the members are holding senior research and management positions in American and multi-national life sciences corporations. Many of our members are experts and leaders, innovative entrepreneurs, lawyers and venture capitalists or investors in the life sciences sector. CABS is the largest and most active Chinese biopharmaceutical association in Northern America. We organize many activities to promote Sino-US collaborations in life sciences and to provide Science & Technology Parks and life sciences companies in China with an excellent platform to promote business and to recruit talent. In addition to year-round technology and business seminars, the annual BioPacific Conference organized by CABS is a highly anticipated event that attracts hundreds of biopharmaceutical professionals and business leaders.
CABS is helping members seeking collaboration opportunties in China
In recent years, China’s life sciences industry has been growing rapidly. Our members are interested in seeking collaboration and partnership opportunities in China. Many of our members are returning to China to start new businesses or assume important research and management positions. To further meet the needs of CABS members, we are actively helping our members seeking partnership opportunities in China in the following areas.
- To co-sponsor scientific conferences in biopharmaceutical field;
- To organize CABS delegations to visit science parks and life sciences companies in China for potential collaborations;
- To serve as a bridge between China and San Francisco Bay Area, to host introductory meetings and business promotion events for delegations of government, science & technology parks and high-tech companies in China;
- To invite leaders in Chinese biopharmaceutical industry to the United States for seminars/talks, especially for the annual CABS ‘BioPacific Conference’;
For more details in cooperation and sponsorship: Click
Email: info@cabsweb.org
President: president@cabsweb.org
北美华人生物医药协会简介
北美华人生物医药协会(美华药协)是一个非盈利性的生物医药专业协会。该协会总部位于旧金山湾区,这里不仅是硅谷所在地, 也是生物科技的起源地及全球最大的生物科技重镇, 有逾千家大小型的生物制药公司,包括几家全球最有影响力的公司Amgen,Genentech和Gilead。我们协会是一个有三千多名成员组成的有重大影响力的生物医药专业协会。成员中70% 拥有生命科学相关领域的博士学位,有相当比例的成员担任美国生物医药公司高级研究及管理职位,不少是生命科学各领域的专家及学术带头人,也有勇于创业创新的企业家, 知识产权律师和风险投资人士。作为北美最大最为活跃的华人生物医药协会,及置身于生物医药第一重镇的独特条件,美华药协广泛开展促进中美生命科学相关领域交流,为中国的科技园区及生命科学相关产业提供一个理想的推介与吸引科技项目与人才的平台。 除我们经常举办的科技与商业研讨会之外,我们每年举办的 BioPacific Conference 太平洋生物大会已被视为生物医药界一个促进中美交流的主要活动之一,吸引来自美国和中国的数百名从事生物制药业的专业人士和企业领袖参加。
北美华人生物医药协会在中国寻求合作
在最近几年里,中国在生命科学相关领域迅速崛起。我们的成员也对回国寻求合作及发展机会表现了极大的兴趣,许多成员已经回国创业或担当重要领导职位。为了进一步满足美华药协成员的需求,我们将在中国积极寻求如下几方面的合作。
- 共同举办药物研发会议/大会;
- 派生物医药考察团携带创业项目考察各地科技园区寻求合作;
- 作为联结中国生物医药业与旧金山湾区生物科技业的主要桥梁,为来自中国的政府、科技园区及企业的代表团组织推介活动及商务洽谈
- 邀请中国生物医药业的领军人士来美做报告, 特别是美华药协举办的 BioPacific Conference 太平洋生物大会;
- 合作与赞助详情: 点击
联系方式: info@cabsweb.org 会长: president@cabsweb.org
To serve biopharmaceutical professionals of Chinese heritage or with professional interests in China, and promote professional interactions
To foster business opportunities and exchanges in the life science industry between the U.S. and China
To promote public awareness of progress and development in the pharmaceutical and biotechnological industry
To collaborate with other organizations in areas of mutual interest
Our Current Sponsors
Organizations in the U.S. and China









